Abstract
Breast Cancer is by far the most common neoplastic disease ofwomen in western industrialized countries. Contrary to public hope and prevailing medical opinion, this tumor is apparently hard to cure, since eventually 60-70% of “radically” resected patients are going to succumb to their disseminated disease within 10 years after surgery [1, 2, 3]. Survival expectancy and mortality have essentially remained unchanged over the past 40 years.
Supported by the Regional Scientific Cancer Program sponsered by the Cancer Leagues of St. Gallen-Appenzell and Thurgau and by the E. E. Schellenberg-Stiftung.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ross W. L.: The magnitude of the breast cancer problem in the USA. Cancer 24, 1106 (1969)
Brinkley D., Haybittle J. L.: The curability of breast cancer. Lancet 2, 95 (1975)
Cutter S. J., Myers M. H., Green S. B.: Trends in survival rates of patients with cancer. N. Engl. J. Med. 293, 122 (1975)
Fisher, B., Slack N. H., Cavanaugh P. J. et al.: Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial. Ann. Surg. 172, 711 (1970)
Stiernswärd J. : Decreased survival related to postoperative radiotherapy in early operable breast cancer? Lancet 2, 1285 (1974)
Fisher B., Ravdin R. G., Ausman R. K., et aI.: Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann. Surge 168, 337 (1968)
Tormey D. C.: Combined chemotherapy and surgery in breast cancer: a review. Cancer 36, 881 (1975)
Fisher B., Carbone P., Economu S. G., et al.: L-PAM in the management of primary breast cancer: a report of early findings. N. EngI. J. Med. 292, 117 (1975)
Bonadonna G., Brusamolino E., Valagussa P.: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N. Engl. J. Med. 294, 405 (1976)
Mutzner F., Amgwerd, R., Gessner U.: Prognose des lokalen primären Mammakarzinoms unter der bisherigen Therapie. Schweiz. Med. Wschr. 107, 992 (1977)
Sparks F. C., Meyerowitz B. E., Ramming K. P., et al.: Adjuvant Chemotherapy and chemoimmunotherapy for breast cancer, in: Adjuvant therapy of cancer, Salmon S. S., Jones St. E. (ed.). Amsterdam—Oxford—New York: North-Holland Publishing company 1977, p. 109
Schabel F. M. jr.: Concepts for systemic treatment of micrometastases. Cancer 35, 15 (1975)
Sutow W. W., Sullivan M. P.: Childhood cancer — the improving prognosis. Postgraduate Medicine 59, 131 (1976)
Rosenberg S. A., Kaplan H. S.: The management of stages I, II and III Hodgkin’s disease with combined radiotherapy and chemotherapy. Cancer 35, 55 (1975)
Burchenal J. H.: A giant step forward - if! New Engl. J. Med. 291, 1029 (1974)
Bonadonna G., Rossi A., Valagussa, P., et al.: Adjuvant chemotherapy with CMFin breast cancer with positive axillary nodes, in: Salmon S. S., Jones S. E. (ed.): Adjuvant therapy of cancer. Amsterdam—Oxford—New York: North-Holland 1977, p. 83
Fisher B., Redmond C., NSABP investigators: Studies of the national surgical adjuvant breast cancer project, in ibidem as (16)
Canellos G. P., DeVita V. T., Gold G. L., et al.: Cyclical combination chemotherapy for advanced breast carcinoma. Brit. Med. J. 1, 218 (1974)
Donovan A., Powell J., Waterhouse J. A. H., et al.: A prolonged course of cyclophsphamide as an adjunct to mastectomy in the primary treatment of breast carcinoma. Br. J. Surg. 63, 817 (1976)
Nissen-Meyer R., Kjellgren K., Mansson B.: Report from the Scandinavian adjuvant chemotherapy study group. 7th Int. Congress of chemotherapy, Prag 1971, abstract 2/B–6/7
Multicentre Breast Cancer Chemotherapy Group: Multimodal therapy for histological stage-II breast cancer. Lancet 2, 396 (1977)
Swiss Group for Clinical Cancer Research: Adjuvante Chemotherapie zur Metastasenprophylaxe beim operierten Mammakarzinom, Studie SAKK–27/76, unpublished observations 1977
Meakin J. W., AlIt W. E. C., Beale F. A., et al.: Ovarian irradiation and prednisone following surgery for carcinoma of the breast, in ibidem as (16)
Holland J. F.: Major advance in breast cancer therapy. editorial. New Engl. J. Med. 294, 440 (1976)
Culliton B. J.: Breast cancer: Reports of new therapy are greatly exaggerated. Science 191, 1029 (1976)
Lerner H.: Second malignancies diagnosed in breast cancer patients while receiving adjuvant chemotherapy at the Pensilvania Hospital. Meeting of the American Soc. Clin. Oncol. (1977), Denver, abstract C-295, p. 340
Sadoff, L., Chan P., Tyson S.: Incidence of second primary cancers in breast cancer patients after prolonged thiotepa therapy. Proc. Am. Assoc. Cancer Res./Am. Soc. Clin. Oncol. 15, 145 (1974)
Ravdin R. G., Lewison E. F., Slack N. H., et al.: Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg. GynecoI. Obstet. 131, 1055 (1970)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Senn, H.J. et al. (1978). Adjuvant Chemo-Immuno-Therapy with LMF+BCG in Node-Negative and Node-Positive Breast Cancer. In: Huber, H., Senn, H., Falkensammer, M. (eds) Adjuvante zytostatische Chemotherapie. Hämatologie und Bluttransfusion, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67111-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-67111-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-09069-4
Online ISBN: 978-3-642-67111-1
eBook Packages: Springer Book Archive